Sun Joins Indian Firms Ramping Up In OTCs To Spread Risk
This article was originally published in PharmAsia News
Executive Summary
Sun Pharma, the world’s fifth-largest generics maker, has become the latest in a string of Indian drug companies to ramp up its interest in the OTC sector as it seeks to buffer its revenue stream from regulatory uncertainties and currency volatility.